Use of Gonadotropin-releasing Hormone Agonists for Ovarian Preservation in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus: A Meta-analysis

被引：0
|
作者：
Ejaz, Komal [1 ]
Abid, Dania [2 ]
Juneau, Paul [3 ]
Chu, Jun [4 ]
Hasni, Sarfaraz [5 ]
机构：
[1] Wright Ctr Grad Med Educ, Scranton, PA USA
[2] Idaho Coll Osteopath Med, Meridian, ID USA
[3] Natl Inst Hlth Lib, Bethesda, MD USA
[4] NIAMS, NIH, Bethesda, MD USA
[5] NIH, Bethesda, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0969
引用
收藏
页码：1912 / 1914
页数：3
相关论文
共 50 条
  • [31] POTENTIAL UTILITY OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN THE MANAGEMENT OF OVARIAN HYPERANDROGENISM
    ADASHI, EY
    [J]. FERTILITY AND STERILITY, 1990, 53 (05) : 765 - 779
  • [32] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    ZHU Hong-lan
    WANG Yan
    LI Xiao-ping
    WANG Chao-hua
    WANG Yue
    CUI Heng
    WANG Jian-liu
    WEI Li-hui
    [J]. 中华医学杂志(英文版), 2013, 126 (04) : 688 - 691
  • [33] Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
    Somers, EC
    Marder, W
    Christman, GM
    Ognenovski, V
    McCune, WJ
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2761 - 2767
  • [34] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    Zhu Hong-lan
    Wang Yan
    Li Xiao-ping
    Wang Chao-hua
    Wang Yue
    Cui Heng
    Wang Jian-liu
    Wei Li-hui
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 688 - 691
  • [35] Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
    Sinha, Rajiv
    Dionne, Janis M.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (05) : 444 - 445
  • [36] The use of gonadotropin-releasing hormone analog in preservation of ovarian function in women undergoing chemotherapy. A systematic review and meta-analysis.
    Bedaiwy, M. A.
    El-Nashar, S. A.
    Desai, N.
    Hafez, F. F. Abdel
    Abdelkader, A. M.
    Falcone, T.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S341 - S341
  • [37] Gonadotropin-Releasing Hormone (GnRH) Agonists for Fertility Preservation: Is POEMS the Final Verse?
    Yu, Bo
    Davidson, Nancy E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (02) : 107 - 108
  • [38] Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
    Abdel-Razeq, Hikmat
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4273 - 4282
  • [39] Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
    Lambertini, Matteo
    Moore, Halle C. F.
    Leonard, Robert C. F.
    Loibl, Sibylle
    Munster, Pamela
    Bruzzone, Marco
    Boni, Luca
    Unger, Joseph M.
    Anderson, Richard A.
    Mehta, Keyur
    Minton, Susan
    Poggio, Francesca
    Albain, Kathy S.
    Adamson, Douglas J. A.
    Gerber, Bernd
    Cripps, Amy
    Bertelli, Gianfilippo
    Seiler, Sabine
    Ceppi, Marcello
    Partridge, Ann H.
    Del Mastro, Lucia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1981 - +
  • [40] Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
    Mok, CC
    Lau, CS
    Wong, RWS
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (05): : 831 - 837
12345